ArticleCJEM2026

Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study.

Mathieu McKinnon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.